| pubmed-article:21764430 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C2607850 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C0281297 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:21764430 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:21764430 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21764430 | pubmed:dateCreated | 2011-9-12 | lld:pubmed |
| pubmed-article:21764430 | pubmed:abstractText | Early-stage epithelial ovarian cancer represents a prognostically heterogenous group. We studied prognostic factors in patients treated with adjuvant paclitaxel/carboplatin chemotherapy. | lld:pubmed |
| pubmed-article:21764430 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21764430 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21764430 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21764430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21764430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21764430 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21764430 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:21764430 | pubmed:issn | 1095-6859 | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:AntsaklisAA | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:RodolakisAA | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:DimopoulosM... | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:BamiasAA | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:ThomakosNN | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:SotiropoulouM... | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:HaidopoulosDD | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:ZagouriFF | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:KaradimouAA | lld:pubmed |
| pubmed-article:21764430 | pubmed:author | pubmed-author:SouposNN | lld:pubmed |
| pubmed-article:21764430 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:21764430 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21764430 | pubmed:volume | 123 | lld:pubmed |
| pubmed-article:21764430 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21764430 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21764430 | pubmed:pagination | 37-42 | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:meshHeading | pubmed-meshheading:21764430... | lld:pubmed |
| pubmed-article:21764430 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21764430 | pubmed:articleTitle | Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience. | lld:pubmed |
| pubmed-article:21764430 | pubmed:affiliation | Department of Clinical Therapeutics, University of Athens, Athens, Greece. abamias@med.uoa.gr | lld:pubmed |
| pubmed-article:21764430 | pubmed:publicationType | Journal Article | lld:pubmed |
